deltatrials
Completed PHASE2 INTERVENTIONAL 2-arm NCT02944799

Alendronate Treatment of Osteoporosis in Rheumatoid Arthritis (ALOSTRA)

Alendronate Treatment of Osteoporosis in Rheumatoid Arthritis - Indication and Duration: A Randomized, Double-blind, Placebocontrolled Study to Evaluate the Effects of Discontinuation of Alendronate in Patients With Both Rheumatoid Arthritis and Low Bone Mass

Sponsor: University of Aarhus

Conditions Osteoporosis Rheumatoid Arthritis
Interventions Alendronate Calcium Placebo Vitamin D
Updated 11 times since 2017 Last updated: Nov 23, 2023 Started: Dec 31, 2015 Primary completion: Dec 20, 2021 Completion: Dec 20, 2021
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02944799, this PHASE2 trial focuses on Osteoporosis and Rheumatoid Arthritis and remains completed. Sponsored by University of Aarhus, it has been updated 11 times since 2015, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotRecruiting~Feb 2017 – ~Jun 2017 · 4 months · monthly snapshotRecruiting~Jun 2017 – ~Jun 2018 · 12 months · monthly snapshotRecruiting~Jun 2018 – ~Nov 2018 · 5 months · monthly snapshotRecruiting~Nov 2018 – ~Aug 2020 · 21 months · monthly snapshotRecruiting~Aug 2020 – ~Jan 2021 · 5 months · monthly snapshotActive Not Recruiting~Jan 2021 – ~Dec 2021 · 11 months · monthly snapshotActive Not Recruiting~Dec 2021 – ~Dec 2023 · 24 months · monthly snapshotActive Not Recruiting~Dec 2023 – ~Jul 2024 · 7 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 24 months · monthly snapshotCompleted

Change History

11 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2

  3. Dec 2023 — Jul 2024 [monthly]

    Completed PHASE2

    Status: Active Not Recruiting → Completed

  4. Dec 2021 — Dec 2023 [monthly]

    Active Not Recruiting PHASE2

  5. Jan 2021 — Dec 2021 [monthly]

    Active Not Recruiting PHASE2

▶ Show 6 earlier versions

  1. Aug 2020 — Jan 2021 [monthly]

    Active Not Recruiting PHASE2

    Status: Recruiting → Active Not Recruiting

  2. Nov 2018 — Aug 2020 [monthly]

    Recruiting PHASE2

  3. Jun 2018 — Nov 2018 [monthly]

    Recruiting PHASE2

  4. Jun 2017 — Jun 2018 [monthly]

    Recruiting PHASE2

  5. Feb 2017 — Jun 2017 [monthly]

    Recruiting PHASE2

  6. Jan 2017 — Feb 2017 [monthly]

    Recruiting PHASE2

    First recorded

Dec 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • University of Aarhus
Data source: University of Aarhus

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations